| FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer T Conroy, P Hammel, M Hebbar, M Ben Abdelghani, AC Wei, JL Raoul, ... New England Journal of Medicine 379 (25), 2395-2406, 2018 | 2400 | 2018 |
| Short-course radiation plus temozolomide in elderly patients with glioblastoma JR Perry, N Laperriere, CJ O˘Callaghan, AA Brandes, J Menten, C Phillips, ... New England Journal of Medicine 376 (11), 1027-1037, 2017 | 1000 | 2017 |
| Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials DJ Sargent, HS Wieand, DG Haller, R Gray, JK Benedetti, M Buyse, ... Journal of Clinical Oncology 23 (34), 8664-8670, 2005 | 781 | 2005 |
| Family satisfaction with care in the intensive care unit: results of a multiple center study DK Heyland, GM Rocker, PM Dodek, DJ Kutsogiannis, E Konopad, ... Critical care medicine 30 (7), 1413-1418, 2002 | 581 | 2002 |
| Intermittent androgen suppression for rising PSA level after radiotherapy JM Crook, CJ O'Callaghan, G Duncan, DP Dearnaley, CS Higano, ... New England Journal of Medicine 367 (10), 895-903, 2012 | 557 | 2012 |
| Role of migratory birds in introduction and range expansion of Ixodes scapularis ticks and of Borrelia burgdorferi and Anaplasma phagocytophilum in Canada NH Ogden, LR Lindsay, K Hanincová, IK Barker, M Bigras-Poulin, ... Applied and environmental microbiology 74 (6), 1780-1790, 2008 | 488 | 2008 |
| Climate change and the potential for range expansion of the Lyme disease vector Ixodes scapularis in Canada NH Ogden, A Maarouf, IK Barker, M Bigras-Poulin, LR Lindsay, ... International journal for parasitology 36 (1), 63-70, 2006 | 488 | 2006 |
| A dynamic population model to investigate effects of climate on geographic range and seasonality of the tick Ixodes scapularis NH Ogden, M Bigras-Poulin, CJ O'callaghan, IK Barker, LR Lindsay, ... International journal for parasitology 35 (4), 375-389, 2005 | 394 | 2005 |
| Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO. 17 SY Brule, DJ Jonker, CS Karapetis, CJ O˘Callaghan, MJ Moore, R Wong, ... European journal of cancer 51 (11), 1405-1414, 2015 | 384 | 2015 |
| Decision-making in the ICU: perspectives of the substitute decision-maker DK Heyland, DJ Cook, GM Rocker, PM Dodek, DJ Kutsogiannis, S Peters, ... Intensive care medicine 29 (1), 75-82, 2003 | 350 | 2003 |
| Risk maps for range expansion of the Lyme disease vector, Ixodes scapularis, in Canada now and with climate change NH Ogden, L St-Onge, IK Barker, S Brazeau, M Bigras-Poulin, ... International Journal of Health Geographics 7 (1), 1-15, 2008 | 339 | 2008 |
| Investigation of Relationships Between Temperature and Developmental Rates of Tick Ixodes scapularis (Acari: Ixodidae) in the Laboratory and Field NH Ogden, LR Lindsay, G Beauchamp, D Charron, A Maarouf, ... Journal of medical entomology 41 (4), 622-633, 2004 | 297 | 2004 |
| End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the … DJ Sargent, S Patiyil, G Yothers, DG Haller, R Gray, J Benedetti, M Buyse, ... Journal of Clinical Oncology 25 (29), 4569-4574, 2007 | 276 | 2007 |
| Dying in the ICU: perspectives of family members DK Heyland, GM Rocker, CJ O˘Callaghan, PM Dodek, DJ Cook Chest 124 (1), 392-397, 2003 | 273 | 2003 |
| Regorafenib for the treatment of advanced gastric cancer (INTEGRATE): a multinational placebo-controlled phase II trial N Pavlakis, KM Sjoquist, AJ Martin, E Tsobanis, S Yip, YK Kang, YJ Bang, ... Journal of Clinical Oncology 34 (23), 2728, 2016 | 227 | 2016 |
| A longitudinal field trial of the effect of biotin on lameness in dairy cows J Hedges, RW Blowey, AJ Packington, CJ O˘Callaghan, LE Green Journal of Dairy Science 84 (9), 1969-1975, 2001 | 221 | 2001 |
| PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer—results from NCIC CTG/AGITG CO. 17 CS Karapetis, D Jonker, M Daneshmand, JE Hanson, CJ O'Callaghan, ... Clinical Cancer Research 20 (3), 744-753, 2014 | 190 | 2014 |
| The seriously ill hospitalized patient: preferred role in end-of-life decision making? DK Heyland, J Tranmer, CJ O'Callaghan, A Gafni Journal of critical care 18 (1), 3-10, 2003 | 161 | 2003 |
| Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO. 17 trial N Mittmann, HJ Au, D Tu, CJ O'Callaghan, PK Isogai, CS Karapetis, ... Journal of the National Cancer Institute 101 (17), 1182-1192, 2009 | 146 | 2009 |
| Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial DJ Jonker, L Nott, T Yoshino, S Gill, J Shapiro, A Ohtsu, J Zalcberg, ... The lancet Gastroenterology & hepatology 3 (4), 263-270, 2018 | 145 | 2018 |
